"We look forward to advancing new skin and hair beauty products that have measurable impact for consumers," said Randal J. Kirk, chairman and CEO of Intrexon. "By combining Intrexon's synthetic biology approaches with the capabilities at Johnson & Johnson Innovation and Johnson & Johnson Consumer & Personal Products Worldwide, we believe that there are multiple areas for new product exploration."
According to the companies, through the collaboration, technical experts at both companies will work together to explore, define, and test new potential products for consumers.
Intrexon Corporation’s proprietary UltraVector platform provides its partners with industrial-scale design and development of complex biological systems. The platform delivers “unprecedented control over the quality, function, and performance of living cells,” according to Intrexon.